FREEDOM: Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements Study
Recruiting in Palo Alto (17 mi)
+40 other locations
BL
Overseen byBertrand L. Jaber, MD, FASN
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: NxStage Medical
No Placebo Group
Trial Summary
What is the purpose of this trial?
Purpose The purpose of this study is to compare the economical impact and clinical parameters of short daily hemodialysis using the NxStage® System One hemodialysis device with thrice-weekly conventional in-center dialysis using a matched cohort from the US Renal Data System (USRDS) database.
Research Team
BL
Bertrand L. Jaber, MD, FASN
Principal Investigator
Unaffilated
Eligibility Criteria
Inclusion Criteria
Diagnosis of ESRD and require dialysis
Medicare as primary payor (NOTE: Does not include Medicare HMO as primary payer)
Candidate for daily hemodialysis (defined as 6 or more times per week)
See 1 more
Treatment Details
Interventions
- Conventional in-center dialysis (Procedure)
- Hemodialysis using NxStage® System One (Procedure)
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Commonwealth DialysisGreenfield, WI
Dialysis Center of LincolnLincoln, NE
Virginia Commonwealth University/Medical College of VirginiaRichmond, VA
Northwest Kidney CentersSeattle, WA
More Trial Locations
Loading ...
Who Is Running the Clinical Trial?
NxStage Medical
Lead Sponsor
Trials
7
Patients Recruited
980+